Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR
Ulrike Litzenburger(German Cancer Research Center), Michael Platten(National Center for Tumor Diseases)
Cited by 309
Related Papers
The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells
|PLoS ONE|2011|143
Promotion of Glioblastoma Cell Motility by Enhancer of Zeste Homolog 2 (EZH2) Is Mediated by AXL Receptor Kinase
|PLoS ONE|2012|50
MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors
|bioRxiv (Cold Spring Harbor Laboratory)|2022|14